ClinicalTrials.gov
public full text
Public Domain
CRC Post-surgical Assessment and Recurrence Monitoring
The surgical therapeutic effect of stage II-IV CRC patients will be assessed by the plasma mSEPT9 assay, and patients will be followed up by the same assay for recurrence monitoring.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease#917823
- Convalescent Plasma for the Treatment of COVID-19#888372
- Metformin for the Prevention of CRA Recurrence#252950
- Postoperative Acute Myocardial Ischemic Injury#810888
- Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice#800752
Record · ID 1072034
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive